Overview
Mitsuyoshi Ueda practices practicing medicine in Kyoto, Japan.
Mr. Ueda is highly rated in 1 condition, according to our data. His clinical expertise encompasses Thrush, Folate Deficiency, Flu, and Sickle Cell Disease.
He is actively involved in clinical research, co-authoring 158 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mitsuyoshi A. Ueda
Is Mitsuyoshi A. Ueda a top-rated expert for Thrush?
MediFind is an objective health platform that identifies experts based on real-world data. Mitsuyoshi A. Ueda is classified as an Advanced expert for Thrush, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mitsuyoshi A. Ueda participate in research or clinical trials?
Yes. Mitsuyoshi A. Ueda has published 158 articles and abstracts on conditions like Thrush. You can view a list of Mitsuyoshi A. Ueda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ThrushMr. Ueda isAdvanced. Learn about Thrush.
- Experienced
- FluMr. Ueda isExperienced. Learn about Flu.
- Folate DeficiencyMr. Ueda isExperienced. Learn about Folate Deficiency.
- Sickle Cell DiseaseMr. Ueda isExperienced. Learn about Sickle Cell Disease.